EXHIBIT 24.3
Published on September 17, 1997
EXHIBIT 24.3
CONSENT OF INDEPENDENT AUDITORS
We consent to inclusion in this Post-Effective Amendment No. 1 to the
Registration Statement on Form SB-2 (333-13409) of our report dated February 7,
1997 (with respect to Note K[2], February 21, 1997) on our audits of the
financial statements of Cytoclonal Pharmaceutics Inc, a Delaware corporation, as
of December 31, 1996 and for each of the years in the two-year period ended
December 31, 1996 and for the period from September 11, 1991 (inception) through
December 31, 1996. We also consent to the reference of our firm under the
captions "Experts" and "Selected Financial Data" in the Prospectus.
Richard A. Elsner & Company, LLP
New York, NY
September 11, 1997